Assessment of the availability of snakebite antivenom in health facilities in Ndola District, Zambia: a cross-sectional study

Scott K. Matafwali, Pipina A. Vlahakis, Victor Daka, Bwalya A. Witika, Herbert T. Nyirenda, Namaunga K. Chisompola, Chiluba Mwila

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND: Despite snakebite antivenom being included on the WHO list of essential medicines, many parts of the world, especially Africa, lack effective and safe antivenoms. METHODS: A descriptive, field-based, cross-sectional study was undertaken from August to November 2020 in 40 out of 71 health facilities in Ndola district. Interviews and physical inspection were conducted at each facility. RESULTS: The study revealed that only three (8%) of all the private health facilities had antivenom available at the time of the assessment. Factors significantly associated with antivenom supply included lack of central country supply (90%), lack of demand of the antivenom (55%) and no budget allocation for the antivenom (95%). CONCLUSIONS: Despite the high number of notified snakebites within Ndola district, there remains poor availability of snakebite antivenom within the district.

Original languageEnglish
Pages (from-to)592-594
Number of pages3
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene
Volume116
Issue number6
DOIs
Publication statusPublished - 1 Jun 2022
Externally publishedYes

Keywords

  • accessibility, antivenom, availability
  • Ndola, snakebites
  • Zambia

Fingerprint

Dive into the research topics of 'Assessment of the availability of snakebite antivenom in health facilities in Ndola District, Zambia: a cross-sectional study'. Together they form a unique fingerprint.

Cite this